<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">335869</id>
  <title nil="true"/>
  <common-name>2-[[4-ethyl-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-(2-methoxyphenyl)prop-2-enylidene]amino]acetamide</common-name>
  <description>2-[[4-ethyl-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-(2-methoxyphenyl)prop-2-enylidene]amino]acetamide is a chemical compound with the formula C23H25N5O3S. It has an average molecular weight of 451.50 g/mol.</description>
  <cas>308096-16-4</cas>
  <pubchem-id>6886157</pubchem-id>
  <chemical-formula>C23H25N5O3S</chemical-formula>
  <weight>451.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T18:07:39Z</created-at>
  <updated-at type="dateTime">2026-08-30T18:07:39Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCN1C(=NN=C1SCC(=O)NN=CC=CC2=CC=CC=C2OC)C3=CC=C(C=C3)OC</moldb-smiles>
  <moldb-formula>C23H25N5O3S</moldb-formula>
  <moldb-inchi>InChI=1S/C23H25N5O3S/c1-4-28-22(18-11-13-19(30-2)14-12-18)26-27-23(28)32-16-21(29)25-24-15-7-9-17-8-5-6-10-20(17)31-3/h5-15H,4,16H2,1-3H3,(H,25,29)/b9-7+,24-15+</moldb-inchi>
  <moldb-inchikey>FGIZJCDQDMNFBX-CLDIPPNSSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">451.1678109</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.6</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM331762</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[4-ethyl-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-(2-methoxyphenyl)prop-2-enylidene]amino]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Triazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0286335</sync-id>
  <structure-inchikey>FGIZJCDQDMNFBX-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>204000000000800000000800000000000000000000000000000000400000000002000002200004000000002080004000000080400000000000200000000000000000000000000000000000000020000000000300000204008010000000040000210000011040200000000000800000000100000040000000000100000000000040000000800000000000000180880000000100000000000040000000000000000000000000000000080000002000000000400000000000102800400080000000004000000040000000000000000000000000002000000200000000000000000000000004001048000000000400000000010020000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAgAAAAIgAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:37:29Z</structure-indexed-at>
</compound>
